Get assets for your articles

We've prepared logos and images of our product, team, and office for your use.

Download Media Kit

Find answers or schedule interviews

Read more about us, look through our help center, or reach out to chat.

Contact Us

Press Articles

BestPlaceToWork_Blog_May2020V1
BenchSci Press Release
BenchSci Certified as Great Place to Work® and Listed as Best Startup Workplace
Certification reflects mission to exponentially increase the speed and quality of life-saving research, and focus on employee health and wellness
AI-Derived COVID-19 Experimental Data and Reagent Insights Now Available from BenchSci
BenchSci Press Release
AI-Derived COVID-19 Experimental Data and Reagent Insights Now Available from BenchSci
Open-access data will help scientists select antibody, RNAi, and protein reagents to expedite development of treatments and vaccines
F-Prime backs a niche AI software startup hunting lofty goals in $22M Series B
Endpoints News
F-Prime backs a niche AI software startup hunting lofty goals in $22M Series B
For many of the AI companies sprouting on the biopharma field, validation — often meaning confirmation of whether the targets and drugs they identified or generated would actually work — won’t come in years, if at all. But for BenchSci, the drug hunting field is their home turf.
BenchSci raises financing to expand artificial intelligence search capability for scientists
The Globe and Mail
BenchSci raises financing to expand artificial intelligence search capability for scientists
Toronto startup BenchSci, which uses AI to help biomedical scientists cut time and costs from research, is extending its reach with a US$22-million fundraising round led by a Fidelity Investments Inc.-linked venture firm.
BenchSci raises $22 million for AI-powered drug discovery tools
Venture Beat
BenchSci raises $22 million for AI-powered drug discovery tools
Assessing the health of pharmaceutical R&D by unearthing hidden patterns in procurement data is a task made simpler by AI.
BenchSci Raises $29 Million CAD Series B Round
Betakit
BenchSci Raises $29 Million CAD Series B Round
BenchSci has raised a $29 million CAD ($22 million USD) Series B funding round led by F-Prime Capital.
BenchSci Raises $22 Million Series B and Launches New AI-Assisted Reagent Selection Product to Optimize $10.2 Billion in Life Science R&D Spend
BenchSci Press Release
BenchSci Raises $22 Million Series B and Launches New AI-Assisted Reagent Selection Product to Optimize $10.2 Billion in Life Science R&D Spend
F-Prime Capital led the round with participation from existing investors including Gradient Ventures, Google’s AI fund.
With Google's Backing, U of T Startup BenchSci Uses AI to Create
U of T News
With Google's Backing, U of T Startup BenchSci Uses AI to Create "Super Scientists"
In less than three years, biomedical firm BenchSci has gone from four people sitting around a table to a 50-strong operation backed by Google.
BenchSci Announces Total Funding of $27.2 Million as Gradient Ventures Increases Investment, Helping to Meet Demand for Toronto Company’s AI Drug Discovery Technology
BenchSci Press Release
BenchSci Announces Total Funding of $27.2 Million as Gradient Ventures Increases Investment, Helping to Meet Demand for Toronto Company’s AI Drug Discovery Technology
Will expand Toronto office and team, and global salesforce.
Sanbio B.V. Partners with BenchSci to Augment Visibility and Purchasability of Its IHC Antibodies
Sanbio B.V.
Sanbio B.V. Partners with BenchSci to Augment Visibility and Purchasability of Its IHC Antibodies
Partnership will leverage BenchSci’s AI to help scientists find MONOSAN® antibodies for running successful IHC experiments.
ABclonal Technology Partners with BenchSci to Boost Discoverability of its Novel Products
ABclonal
ABclonal Technology Partners with BenchSci to Boost Discoverability of its Novel Products
Partnership will leverage BenchSci’s AI to help scientists find the right reagents and enable ABclonal to compete on product quality.
Biotech Chief Data Officer Milind Kamkolkar Joins Advisory Board of AI-Powered Life Science R&D Accelerator BenchSci
BenchSci Press Release
Biotech Chief Data Officer Milind Kamkolkar Joins Advisory Board of AI-Powered Life Science R&D Accelerator BenchSci
Appointment reinforces Google AI fund-backed company's leadership in using machine learning to drive faster, more cost-effective, and higher impact biomedical discoveries.
Active Motif Partners with BenchSci to Increase Discoverability of Epigenetics-related Products
Active Motif
Active Motif Partners with BenchSci to Increase Discoverability of Epigenetics-related Products
Partnership will leverage BenchSci’s artificial intelligence to help researchers find the right antibodies faster than ever before.
Gradient Ventures Founding Partner Ankit Jain Joins Board of Biomedical AI Startup BenchSci
BenchSci Press Release
Gradient Ventures Founding Partner Ankit Jain Joins Board of Biomedical AI Startup BenchSci
Appointment made as BenchSci announces a more than 5x increase in biomedical experiments understood by its machine learning technology.
Proteintech Partners With BenchSci to Boost Researchers' Antibody Data Searches
Proteintech
Proteintech Partners With BenchSci to Boost Researchers' Antibody Data Searches
Partnership will accelerate science with "rocket fuel" that lets researchers make better decisions faster than ever before.
GeneTex Partners With BenchSci to Augment Antibody Catalog Publication Data
GeneTex
GeneTex Partners With BenchSci to Augment Antibody Catalog Publication Data
Partnership will use BenchSci's artificial intelligence to help researchers run successful experiments with the right antibody.
Bio-Techne Partners with BenchSci to Enhance Available Publication Data of Its Commercial Antibodies
Bio-Techne
Bio-Techne Partners with BenchSci to Enhance Available Publication Data of Its Commercial Antibodies
Novus Biologicals and R&D Systems will list their catalog of antibodies on BenchSci to increase the amount of published antibody validation data available to researchers.
Accomplished Life Science Entrepreneur Karen Padgett Joins BenchSci Advisory Board
BenchSci Press Release
Accomplished Life Science Entrepreneur Karen Padgett Joins BenchSci Advisory Board
Karen's experience will ensure we solve our suppliers' most pressing problems with purpose-built solutions.
Thermo Fisher Scientific to Provide Antibody Publication Data on its Website
Thermo Fisher Scientific
Thermo Fisher Scientific to Provide Antibody Publication Data on its Website
Researchers can view published data on antibodies directly on the website to help better understand antibody performance.
BenchSci Ranked One of the Top 25 Up and Coming Technology Companies on the Branham300
BenchSci Press Release
BenchSci Ranked One of the Top 25 Up and Coming Technology Companies on the Branham300
Recognition follows news of BenchSci becoming the first non-US company to receive investment from Gradient Ventures, Google’s AI-focused venture fund.
Lab Launch Inc. Partners with BenchSci to Provide Startups Time-Saving Research Tools
Lab Launch
Lab Launch Inc. Partners with BenchSci to Provide Startups Time-Saving Research Tools
BenchSci, an AI-driven platform that decodes published figures to help scientists find antibody usage data, is partnering with Lab Launch Inc., a nonprofit biotechnology incubator supporting startups in the Los Angeles area.
The Path to VICTORy – a Beginner's Guide to Success Using Commercial Research Antibodies
The Company of Biologists
The Path to VICTORy – a Beginner's Guide to Success Using Commercial Research Antibodies
Author Simon L. Goodman cites BenchSci as a tool that can help address issues with antibodies that contribute to the reproducibility crisis.
Karger Publishers Partners with BenchSci to Help Scientists Find the Right Products for Their Experiments
Karger
Karger Publishers Partners with BenchSci to Help Scientists Find the Right Products for Their Experiments
Researchers can find biological product data faster on BenchSci’s platform, saving time and helping increase the speed of scientific discovery.
Canada's BenchSci Gets Cash Infusion from Google Parent Alphabet
CBC
Canada's BenchSci Gets Cash Infusion from Google Parent Alphabet
"Tom Leung, co-founder and chief scientist of BenchSci, talks about Google’s parent, Alphabet, investing millions in the Toronto biomedical startup, which uses AI to help scientists sift through research papers for scientific discoveries and product reviews."
Alphabet's AI Venture Capital Firm Makes First Investment in Canada with BenchSci
The Globe and Mail
Alphabet's AI Venture Capital Firm Makes First Investment in Canada with BenchSci
"Alphabet Inc.’s nascent artificial-intelligence venture fund has picked its first Canadian investment: BenchSci, a Toronto biomedical startup that uses machine learning to scan millions of data points in biomedical research papers, generating searchable results to help shorten the drug discovery process."
BenchSci Raises US$8 Million Series A to Accelerate Biomedical Discoveries with AI-Powered Search Engine for Biological Products
BenchSci Press Release
BenchSci Raises US$8 Million Series A to Accelerate Biomedical Discoveries with AI-Powered Search Engine for Biological Products
Latest round of funding from iNovia Capital, Gradient Ventures, and others positions BenchSci to execute on its mission, and take its place in the market as one of the world’s top machine learning companies.
Responsible Science
Science: Disrupt
Responsible Science
BenchSci CSO Tom Leung contributes to a discussion on startups making science more responsible through new technologies and tools.
Wiley Partners with BenchSci to Give Scientists Unprecedented Insight into Biological Products
BenchSci Press Release
Wiley Partners with BenchSci to Give Scientists Unprecedented Insight into Biological Products
John Wiley and Sons Inc. today announced that it has partnered with BenchSci, a life science machine learning software startup, that aims to improve the speed and effectiveness of selecting biological products for experiments.
Biomedical Researchers to Benefit from New Partnership Between Springer Nature and BenchSci
Springer Nature
Biomedical Researchers to Benefit from New Partnership Between Springer Nature and BenchSci
Springer Nature has partnered with BenchSci, making data from over 200 of the world's top journals available to assist scientists in finding biological products for experiments.
Top 17 Research Tools of 2017
LabWorm
Top 17 Research Tools of 2017
BenchSci made LabWorm's top 17 trending research tools of 2017 that were most appreciated and used by the LabWorm community.
In the Lab of the Future, Robots Run Experiments While Scientists Sleep
Forbes
In the Lab of the Future, Robots Run Experiments While Scientists Sleep
"When it comes to experimental design, companies like BenchSci use artificial intelligence to streamline the process, in this case by finding antibodies to target proteins of interest."
BenchSci’s David Chen: Startup CTOs Need to Be Ready for ‘Unknown Unknowns’
BetaKit
BenchSci’s David Chen: Startup CTOs Need to Be Ready for ‘Unknown Unknowns’
Our CTO, David Chen, was featured in startup news publication BetaKit about using machine learning to help medical researchers solve complex medical challenges.
Game Changer: Benchsci
UHN Research
Game Changer: Benchsci
"BenchSci’s platform will effectively standardize experimental protocols, increase researchers’ productivity, and prevent usage of inappropriate antibodies that lead to erroneous results."
MilliporeSigma Hosts Leading Scientists at Life Science Symposium in Greater Boston
MilliporeSigma
MilliporeSigma Hosts Leading Scientists at Life Science Symposium in Greater Boston
BenchSci CEO and co-founder Liran Belenzon joined world-renowned academic researchers, technology experts, and industry entrepreneurs to speak about advances and opportunities in life science.
ASPET Partners with BenchSci to Increase Discoverability of Its Journals
BenchSci Press Release
ASPET Partners with BenchSci to Increase Discoverability of Its Journals
BenchSci will now include four ASPET journals on its platform to increase discoverability of relevant scientific compounds discussed within ASPET-published articles.
The Great Reproducibility Problem
Laboratory News
The Great Reproducibility Problem
"Using filters for specific experimental contexts, BenchSci can help scientists quickly and easily identify the most relevant published figures and associated antibodies within seconds, ensuring that scientists can make an evidence-based decision on antibody selection."
BenchSci Partners with The FASEB Journal to Increase Discoverability of Content
BenchSci Press Release
BenchSci Partners with The FASEB Journal to Increase Discoverability of Content
BenchSci will now include FASEB’s flagship publication, The FASEB Journal (FJ), on its platform to increase discoverability of relevant scientific compounds discussed within The FASEB Journal-published articles.
Science Startups Make Research Faster, Cheaper, More Accurate
Globe and Mail
Science Startups Make Research Faster, Cheaper, More Accurate
"BenchSci has taught a computer to read scientific papers and identify the specific antibodies used as well as other variables, such as specific techniques, tissues and disease used in the experiment."